Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

1.

Myocardial remodeling in diabetic cardiomyopathy associated with cardiac mast cell activation.

Huang ZG, Jin Q, Fan M, Cong XL, Han SF, Gao H, Shan Y.

PLoS One. 2013;8(3):e60827. doi: 10.1371/journal.pone.0060827. Epub 2013 Mar 29.

PMID:
23556005
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid.

Li CJ, Lv L, Li H, Yu DM.

Cardiovasc Diabetol. 2012 Jun 19;11:73. doi: 10.1186/1475-2840-11-73.

PMID:
22713251
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Targeted inhibition of calpain reduces myocardial hypertrophy and fibrosis in mouse models of type 1 diabetes.

Li Y, Ma J, Zhu H, Singh M, Hill D, Greer PA, Arnold JM, Abel ED, Peng T.

Diabetes. 2011 Nov;60(11):2985-94. doi: 10.2337/db10-1333. Epub 2011 Sep 12.

PMID:
21911754
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Cardiac mast cells mediate left ventricular fibrosis in the hypertensive rat heart.

Levick SP, McLarty JL, Murray DB, Freeman RM, Carver WE, Brower GL.

Hypertension. 2009 Jun;53(6):1041-7. doi: 10.1161/HYPERTENSIONAHA.108.123158. Epub 2009 Apr 27.

PMID:
19398662
[PubMed - indexed for MEDLINE]
Free Article
5.

Assessment of cardiac inflammation and remodeling during the development of streptozotocin-induced diabetic cardiomyopathy in vivo: a time course analysis.

Becher PM, Lindner D, Fröhlich M, Savvatis K, Westermann D, Tschöpe C.

Int J Mol Med. 2013 Jul;32(1):158-64. doi: 10.3892/ijmm.2013.1368. Epub 2013 May 2.

PMID:
23652584
[PubMed - indexed for MEDLINE]
6.

Therapeutic effects of neuregulin-1 in diabetic cardiomyopathy rats.

Li B, Zheng Z, Wei Y, Wang M, Peng J, Kang T, Huang X, Xiao J, Li Y, Li Z.

Cardiovasc Diabetol. 2011 Jul 29;10:69. doi: 10.1186/1475-2840-10-69.

PMID:
21798071
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Overexpression of human C-reactive protein exacerbates left ventricular remodeling in diabetic cardiomyopathy.

Mano Y, Anzai T, Kaneko H, Nagatomo Y, Nagai T, Anzai A, Maekawa Y, Takahashi T, Meguro T, Yoshikawa T, Fukuda K.

Circ J. 2011;75(7):1717-27. Epub 2011 Apr 26.

PMID:
21519150
[PubMed - indexed for MEDLINE]
Free Article
8.

Azelnidipine prevents cardiac dysfunction in streptozotocin-diabetic rats by reducing intracellular calcium accumulation, oxidative stress and apoptosis.

Kain V, Kumar S, Sitasawad SL.

Cardiovasc Diabetol. 2011 Nov 4;10:97. doi: 10.1186/1475-2840-10-97.

PMID:
22054019
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Excess protein O-GlcNAcylation and the progression of diabetic cardiomyopathy.

Fricovsky ES, Suarez J, Ihm SH, Scott BT, Suarez-Ramirez JA, Banerjee I, Torres-Gonzalez M, Wang H, Ellrott I, Maya-Ramos L, Villarreal F, Dillmann WH.

Am J Physiol Regul Integr Comp Physiol. 2012 Oct 1;303(7):R689-99. doi: 10.1152/ajpregu.00548.2011. Epub 2012 Aug 8.

PMID:
22874425
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

FT011, a new anti-fibrotic drug, attenuates fibrosis and chronic heart failure in experimental diabetic cardiomyopathy.

Zhang Y, Edgley AJ, Cox AJ, Powell AK, Wang B, Kompa AR, Stapleton DI, Zammit SC, Williams SJ, Krum H, Gilbert RE, Kelly DJ.

Eur J Heart Fail. 2012 May;14(5):549-62. doi: 10.1093/eurjhf/hfs011. Epub 2012 Mar 14.

PMID:
22417655
[PubMed - indexed for MEDLINE]
11.

[Diabetic cardiomyopathy].

Huang YQ, Wang X, Kong W.

Sheng Li Ke Xue Jin Zhan. 2010 Feb;41(1):31-6. Review. Chinese.

PMID:
21417012
[PubMed - indexed for MEDLINE]
12.

Angiotensin-converting enzyme-2 overexpression improves left ventricular remodeling and function in a rat model of diabetic cardiomyopathy.

Dong B, Yu QT, Dai HY, Gao YY, Zhou ZL, Zhang L, Jiang H, Gao F, Li SY, Zhang YH, Bian HJ, Liu CX, Wang N, Xu H, Pan CM, Song HD, Zhang C, Zhang Y.

J Am Coll Cardiol. 2012 Feb 21;59(8):739-47. doi: 10.1016/j.jacc.2011.09.071.

PMID:
22340266
[PubMed - indexed for MEDLINE]
Free Article
13.

p53 promotes cardiac dysfunction in diabetic mellitus caused by excessive mitochondrial respiration-mediated reactive oxygen species generation and lipid accumulation.

Nakamura H, Matoba S, Iwai-Kanai E, Kimata M, Hoshino A, Nakaoka M, Katamura M, Okawa Y, Ariyoshi M, Mita Y, Ikeda K, Okigaki M, Adachi S, Tanaka H, Takamatsu T, Matsubara H.

Circ Heart Fail. 2012 Jan;5(1):106-15. doi: 10.1161/CIRCHEARTFAILURE.111.961565. Epub 2011 Nov 9. Erratum in: Circ Heart Fail. 2014 Mar 1;7(2):383.

PMID:
22075967
[PubMed - indexed for MEDLINE]
Free Article
14.

Myocardial adipose triglyceride lipase overexpression protects diabetic mice from the development of lipotoxic cardiomyopathy.

Pulinilkunnil T, Kienesberger PC, Nagendran J, Waller TJ, Young ME, Kershaw EE, Korbutt G, Haemmerle G, Zechner R, Dyck JR.

Diabetes. 2013 May;62(5):1464-77. doi: 10.2337/db12-0927. Epub 2013 Jan 24.

PMID:
23349479
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene.

Tschöpe C, Walther T, Königer J, Spillmann F, Westermann D, Escher F, Pauschinger M, Pesquero JB, Bader M, Schultheiss HP, Noutsias M.

FASEB J. 2004 May;18(7):828-35.

PMID:
15117887
[PubMed - indexed for MEDLINE]
Free Article
16.

Transplantation of bone marrow-derived endothelial progenitor cells attenuates myocardial interstitial fibrosis and cardiac dysfunction in streptozotocin-induced diabetic rats.

Cheng Y, Guo S, Liu G, Feng Y, Yan B, Yu J, Feng K, Li Z.

Int J Mol Med. 2012 Oct;30(4):870-6. doi: 10.3892/ijmm.2012.1083. Epub 2012 Jul 31.

PMID:
22859217
[PubMed - indexed for MEDLINE]
17.

Cardiac contractile dysfunction and apoptosis in streptozotocin-induced diabetic rats are ameliorated by garlic oil supplementation.

Ou HC, Tzang BS, Chang MH, Liu CT, Liu HW, Lii CK, Bau DT, Chao PM, Kuo WW.

J Agric Food Chem. 2010 Oct 13;58(19):10347-55. doi: 10.1021/jf101606s.

PMID:
20836552
[PubMed - indexed for MEDLINE]
18.

Therapeutic effect of MG-132 on diabetic cardiomyopathy is associated with its suppression of proteasomal activities: roles of Nrf2 and NF-κB.

Wang Y, Sun W, Du B, Miao X, Bai Y, Xin Y, Tan Y, Cui W, Liu B, Cui T, Epstein PN, Fu Y, Cai L.

Am J Physiol Heart Circ Physiol. 2013 Feb 15;304(4):H567-78. doi: 10.1152/ajpheart.00650.2012. Epub 2012 Dec 7.

PMID:
23220333
[PubMed - indexed for MEDLINE]
Free Article
19.

CCN2 protein is an announcing marker for cardiac remodeling following STZ-induced moderate hyperglycemia in mice.

Kamiński KA, Szepietowska B, Bonda T, Kozuch M, Mencel J, Małkowski A, Sobolewski K, Kovalchuk O, Chyczewski L, Szelachowska M, Górska M, Musiał WJ, Winnicka MM.

Pharmacol Rep. 2009 May-Jun;61(3):496-503.

PMID:
19605949
[PubMed - indexed for MEDLINE]
Free Article
20.

Cardiac remodeling rather than disturbed myocardial energy metabolism is associated with cardiac dysfunction in diabetic rats.

Bollano E, Omerovic E, Svensson H, Waagstein F, Fu M.

Int J Cardiol. 2007 Jan 8;114(2):195-201. doi: 10.1016/j.ijcard.2006.01.027.

PMID:
21882490
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk